JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Poshmark Inc. (POSH) Announces IPO Registration Statement Filing
-
Poshmark, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Gamida Cell (GMDA) Prices $65 Million Public Offering of Ordinary Shares at $8/sh
-
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
-
Midwest Holding Inc. Announces Pricing of Public Offering
-
Gamida Cell Ltd. (GMDA) Announces Proposed Common Share Offering
-
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
-
Upstart Holdings (UPST) IPO Opens 30% Higher
-
Demandbase Expands ABM Ecosystem with Multiple Strategic Product Integrations for Demandbase One
-
Upstream Worldwide, Inc. (UPST) Prices 9M Share IPO at $20/Sh
-
Ocular Therapeutix (OCUL) Prices 3.725M Share Common Offering at $21.50/Sh
-
Upstart Announces Pricing of Initial Public Offering
-
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
-
Root to Host Video Webcast for Investors: A Deeper Dive into the Data Science Expertise at Root Insurance with JMP Securities
-
Root to Host Video Webcast for Investors: A Deeper Dive into the Data Science Expertise at Root Insurance with JMP Securities
-
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
PubMatic Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
BioCryst to Present at JMP Securities Hematology Summit
-
ERYTECH to Present at the JMP Securities Hematology Summit
-
ERYTECH to Present at the JMP Securities Hematology Summit
-
Airbnb (ABNB) IPO Opens 115% Higher
-
JMP Securities Downgrades Neos Therapeutics (NEOS) to Market Perform, Following Acquisition
-
5 Best Penny Stocks To Buy After Pfizer's FDA News? 1 With 102% Target
-
Next Insurance Acquires Juniper Labs
-
Kura Oncology to Participate in the JMP Securities Hematology Summit
-
Airbnb Inc. (ABNB) Prices 51.32M Class A Share IPO at $68/Sh
-
Airbnb Announces Pricing of Initial Public Offering
-
DoorDash (DASH) IPO Opens 78% Higher
-
C3.ai (AI) IPO Opens 138% Higher
-
Stifel Financial (SF) PT Raised to $80 at JMP Securities
-
Midwest Holding Inc. Announces Launch of Public Offering
-
PubMatic (PUBM) IPO Opens 26% Higher
-
C3.ai (AI) Prices 15.5M Class A Share IPO at $42/Sh
-
PubMatic Inc. (PUBM) Prices 5.9M Share Class A Offering at $20/Sh
-
Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh
-
Kura Oncology (KURA) Prices 8.11M Share Common Offering at $37/Sh
-
DoorDash, Inc. (DASH) Prices 33M Share Class A IPO at $102/Sh
-
PubMatic Announces Pricing of Initial Public Offering
-
C3.ai Announces Pricing of Initial Public Offering
-
Sutro Biopharma Announces Pricing of $126.0 Million Public Offering
-
Kura Oncology Announces Pricing of $300 Million Public Offering of Common Stock
-
DoorDash Announces Pricing of Initial Public Offering
-
Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit
-
Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit
-
CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15
-
Veritone, Inc. Announces Closing of $63.8 Million Upsized Public Offering of Common Stock
-
Sutro Biopharma (STRO) Announces Proposed Public Offering of 5 Million Shares of Common Stock
-
Sutro Biopharma Announces Proposed Public Offering of 5 Million Shares of Common Stock
-
Turmeric Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 7, 2020

